Ann: Phase IIB Clinical Trial of Schedule 3, page-18

According to BOD, in a month's time we'll have an answer. Hopefully a positive one for insomniacs and BOD shareholders.

For those who know much more than me, what is usually the efficacious threshold that TGA uses to determine if a product gains approval?

Also came across this news story from last November on the CAN Rest trial (even reference to smart watches that Jo mentioned in the webinar).

Acknowledgements to anyone who has previously posted

https://www.woolcock.org.au/news/can-cannabis-help-you-sleep-better

If this is successful, it will be a global news story in the CBD field